Sleep duration has been shown to play an important role in the development of cancer. However, the results have been inconsistent. A meta-analysis with prospective cohort studies was performed to clarify the association between short or long sleep duration and cancer risk.
PubMed and Embase databases were searched for eligible publications. Pooled relative risk (RR) with 95% confidence interval (CI) was calculated using random- or fixed- model.
A total of 10 prospective studies (8392 incident cases and 555678 participants) were included in the meta-analysis. Neither short nor long sleep duration was statistically associated with increased risk of cancer (short sleep duration: RR=1.05, 95%CI=0.90-1.24, p=0.523; long sleep duration: RR=0.92, 95%CI=0.76-1.12, p=0.415). In the subgroup by cancer type, long sleep duration was positively associated with colorectal cancer (RR=1.29, 95%CI=1.09-1.52, p=0.003).
The present meta-analysis suggested that neither short nor long sleep duration was significantly associated with risk of cancer, although long sleep duration increased risk of with colorectal cancer. Large-scale well-design prospective studies are required to be conducted to further investigate the observed association.
Citation: Lu Y, Tian N, Yin J, Shi Y, Huang Z (2013) Association between Sleep Duration and Cancer Risk: A Meta-Analysis of Prospective Cohort Studies. PLoS ONE 8(9): e74723. doi:10.1371/journal.pone.0074723
Editor: Manlio Vinciguerra, University College London, United Kingdom
Received: June 1, 2013; Accepted: August 5, 2013; Published: September 4, 2013
Copyright: © 2013 Lu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing interests: The authors have declared that no competing interests exist.
Cancer is a serious public health problem worldwide. Although many risk factors, including genetic variants, obesity, intake of high-fat food, lack of physical activity, smoking and alcohol consumption, contribute to development of cancer, they can account for only a small proportion of cancer cases. Thus, other unknown risk factors still need to be identified.
Melatonin, synthesized and secreted by the pineal gland in the brain, plays an important role in controlling the body’s circadian rhythm . Evidence has shown that serum melatonin concentrations are lower in habitual short sleepers (<6 h/night) than in long sleepers (>9 h/night) . Thus, sleep duration may influence melatonin levels by determining length of light exposure, thereby affecting cancer risk. Recently, several meta-analyses have indicated that both short and long sleep durations are associated with risk of obesity [3,4], hypertension [5,6], diabetes , cardiovascular disease , as well as all-cause mortality [9,10]. However, no meta-analysis has been performed to investigate the association between habitual sleep duration and cancer risk, although 10 prospective cohort studies have been conducted and the findings have been inconsistent [11–19]. The discrepancy might be due to the insufficient statistical power of individual study. In this study, therefore, we performed a meta-analysis to clarify the association between sleep duration and cancer risk.
Materials and Methods
Literature and search strategy
Literature databases were searched including PubMed and Embase. The search strategy to identify all possible studies involved the use of the following key words: (sleep duration or sleep time) and (cancer or carcinoma). The reference lists of retrieved articles were hand-searched. The literature search was limited to English language. If more than one article were published using the same data, only the study with largest sample size was included. The literature search was updated on May 11, 2013.
Inclusion criteria and data extraction
The studies included in the meta-analysis met the following inclusion criteria: (1) evaluated the association between sleep duration and cancer risk; (2) used cohort design; (3) provided relative risk (RR) with 95% confidence interval (CI). The following information was extracted from each study: (1) name of the first author; (2) year of publication; (3) origin of country; (4) number of incident cancer cases and total participants; (5) sex ratio and mean age of the study population; (6) duration of follow-up; (7) sleep duration category; (8) cancer type; (9) covariates used in adjustment. The two authors independently assessed the articles for compliance with the inclusion/exclusion criteria and resolved disagreements through discussion.
The association of short or long sleep duration with cancer risk was estimated by calculating pooled RR and 95% CI. The significance of pooled RR was determined by Z test (p<0.05 was considered statistically significant). A Q test was performed to examine the between-study heterogeneity. A random- (DerSimonian-Laird method ) or fixed- (Mantel-Haenszel method ) effects model was used to calculate pooled RR in the presence (p<=0.10) or absence (p>0.10) of heterogeneity, respectively. Subgroup analysis based on cancer type was conducted. Sensitivity analysis after excluding one study at a time was performed to assess the stability of the results. Publication bias was assessed by Begg’s test  and Egger’s test  (p<0.05 was considered statistically significant). Statistical analysis was conducted using STATA version 11 (StataCorp LP, College Station, Texas, USA).
Characteristics of the studies
The PRISMA checklist was presented as Table S1. A flow chart for exclusion/inclusion of individual articles (or studies) was presented as Figure 1. The literature search identified a total of 274 potentially relevant papers. 253 papers were excluded after reading the title and abstract because of obvious irrelevance. One paper was excluded since it examined the association between sleep duration and breast cancer OncotypeDX recurrence score. Another paper was excluded because it investigated the association between sleep duration and colorectal adenoma. In addition, four letters and two commentaries were also excluded. Thus, 13 papers met the inclusion criteria. However, four case-control studies were further excluded [24–27]. In addition, since two studies were included in the paper by Zhang et al. , they were considered as the separate studies in the following data analysis. Therefore, a total of 9 articles including 10 studies (8392 incident cases and 555678 participants) were included in the final meta-analysis [11–19]. Of them, six studies were on breast cancer, three on colorectal cancer, one on prostate cancer, one on endometrial cancer, one on thyroid cancer, and one on ovarian cancer. Sleep duration category (hours) and other characteristics of the included studies were presented in Table 1.
|Study||Country||No. of cases||No. of participants||Sex (male, %)||Age (mean ±SD or age range, years)||Follow-up period (years)||Sleep duration category (hours)||Cancer type||Adjustment|
|Verkasalo et al, 2005 ||Finland||242||11980||All were women||36.5||6||Referent=‘7–8’; Short=‘≤6’; Long=‘≥9’||Breast cancer||Age, zygosity, social class, number of children, use of oral contraceptives, body mass index, alcohol use, smoking, physical activity|
|Pinheiro et al, 2006 ||Austria||4223||73195||All were women||30-50||16||Referent=‘7’; Short=‘≤5’; Long=‘≥9’||Breast cancer||Age, body mass index, height,history of benign breast disease, family history of breast cancer, parity and age at first birth, age at menarche, age at menopause, postmenopausal hormone use, physical activity, smoking.|
|Kakizaki et al, 2008 ||Japan||143||23852||All were women||40–79||9||Referent=‘7’; Short=‘≤6’; Long=‘≥9’||Breast cancer||Age; body mass index; history of diseases; family history of cancer; job; marital status; education; cigarette smoking; alcohol consumption; time spent walking; total caloric intake; menopausal status; age at menarche; age at first delivery; number of deliveries; using of oral contraceptive drugs ; using of hormone drugs except for oral contraceptive drugs|
|Kakizaki, et al, 2008 ||Japan||127||22193||All were men||40–79||9||Referent=‘7–8’; Short=‘≤6’; Long=‘≥9’||Prostate cancer||Age; marital status; education; job status; history of diseases; family history of cancer ; body mass index; cigarette smoking; alcohol consumption; walking status|
|Sturgeon et al, 2012 ||USA||452||48273||All were women||50–79||7.5||Referent=‘7’; Short=‘≤6’; Long=‘≥9’||Endometrial cancer||Age, race, body mass index, smoking, number of live births, physical activity, unopposed estrogen use, oral contraceptive use, and family history of endometrial cancer|
|Luo et al, 2012 ||USA||295||142638||All were women||50–79||11||Referent=‘7–8’; Short=‘≤6’; Long=‘≥9’||Thyroid Cancer||Age at enrollment, ethnicity, educational level, smoking, BMI, recreational physical activity, alcohol intake, family history of cancer, previous thyroid disease, history of hormone therapy use, depression score, and different treatment assignments for Women’s Health Initiative clinical trials|
|Weiderpass et al, 2012 ||Japan||86||45662||All were women||40–69||7.6||Referent=‘6–7’; Short=‘<6’; Long=‘>7’||Ovarian cancer||Age, study center, age at menarche, nulliparous, parity, age at first birth, breastfeeding, use of exogenous hormones, menopausal status at enrollment, height, body mass index, smoking status, exposure to second-hand smoke, alcohol consumption, physical activity, family history of cancer|
|Jiao et al, 2013 ||USA||851||74977||All were women||63±7||11.3||Referent=‘7’; Short=‘≤5’; Long=‘≥9’||Colorectal cancer||Age, ethnicity, fatigue, hormone replacement therapy, waist to hip ratio, and physical activity|
|Zhang et al, 2013 ||USA||709||29412||All were men||41-79||22||Referent=‘7’; Short=‘≤5’; Long=‘≥9’||Colorectal cancer||Age, smoking before age 30, history of colorectal cancer in a parent or sibling, history of endoscopy, regular aspirin use, physical activity, snoring, body mass index, history of diabetes, beef, pork, and lamb as a main dish, consumption of processed meat, alcohol consumption, energy-adjusted total calcium intake, total folate, and total vitamin D intake|
|Zhang et al, 2013 ||USA||1264||75104||All were women||40-73||22||Referent=‘7’; Short=‘≤5’; Long=‘≥9’||Colorectal cancer||Age, smoking before age 30, history of colorectal cancer in a parent or sibling, history of endoscopy, regular aspirin use, physical activity, snoring, body mass index, history of diabetes, beef, pork, and lamb as a main dish, consumption of processed meat, alcohol consumption, energy-adjusted total calcium intake, total folate, total vitamin D intake, postmenopausal hormone use|
Short sleep duration was not statistically associated with increased risk of cancer (RR=1.05, 95%CI=0.90-1.24, p=0.523; Figure 2 and Table 2) with evidence of between-study heterogeneity (I2=57.6%, p for heterogeneity=0.012). In the subgroup by cancer type, non-significant association was also found for all cancers (Table 2).
|Group||No. of studies (incident cases)||RR||95%CI||P z||Statistical model||I2 (%)||P H|
|Breast cancer||3 (4608)||1.06||0.75-1.49||0.739||Random||66.3||0.051|
|Colorectal cancer||3 (2824)||1.12||0.84-1.49||0.449||Fixed||55.2||0.107|
|Prostate cancer||1 (127)||1.38||0.77-2.48||0.280||-||-||-|
|Endometrial cancer||1 (452)||0.95||0.75-1.20||0.669||-||-||-|
|Thyroid cancer||1 (295)||0.79||0.61-1.02||0.072||-||-||-|
|Ovarian cancer||1 (86)||2.00||0.89-4.47||0.091||-||-||-|
|Breast cancer||3 (4608)||0.88||0.73-1.07||0.192||Fixed||15.1||0.308|
|Colorectal cancer||3 (2824)||1.29||1.09-1.52||0.003||Fixed||5.8||0.346|
|Prostate cancer||1 (127)||0.36||0.18-0.72||0.004||-||-||-|
|Endometrial cancer||1 (452)||0.83||0.49-1.40||0.487||-||-||-|
|Thyroid cancer||1 (295)||0.74||0.39-1.40||0.353||-||-||-|
|Ovarian cancer||1 (86)||0.80||0.65-0.99||0.038||-||-||-|
Long sleep duration was not statistically associated with increased risk of cancer (RR=0.92, 95%CI=0.76-1.12, p=0.415; Figure 3 and Table 2) with evidence of between-study heterogeneity (I2=68.9%, p for heterogeneity=0.001). In the subgroup by cancer type, long sleep duration was positively associated with colorectal cancer (RR=1.29, 95%CI=1.09-1.52, p=0.003), but inversely associated with prostate cancer (RR=0.36, 95%CI=0.18-0.72, p=0.004) and ovarian cancer (RR=0.80, 95%CI=0.65-0.99, p=0.038). There was no significant association of long sleep duration with endometrial cancer and thyroid cancer (Table 2).
Sensitivity analysis and publication bias
After excluding one study at a time, the sensitivity analysis confirmed the non-significant association between sleep duration and cancer risk (data not shown). No publication bias was detected for short sleep duration (Begg’s test: p= 0.592 and Egger’s test: p= 0.349) and long sleep duration (Begg’s test: p= 0.210 and Egger’s test: p= 0.374).
To the best of our knowledge, this is the first meta-analysis with prospective cohort studies examining the association between sleep duration and cancer risk. The findings showed that neither short nor long sleep duration was significantly associated with cancer risk. In the subgroup analysis by cancer type, we found long sleep duration was positively associated with colorectal cancer, but inversely associated with prostate cancer and ovarian cancer.
To date, six studies have investigated the association between sleep duration and breast cancer and have revealed mixed results [11–13,25–27]. Three studies were cohort based [11–13] and the other three studies were case-control based [25–27]. In this meta-analysis, we did not recruit three case-control studies since they limit casual inference. The pooling of the RRs from three cohort studies did not suggest any association for either short or long sleep duration with breast cancer. In the subgroup analysis by cancer type, we observed positive association between long sleep duration and colorectal cancer risk. This finding was based on three cohort studies including 2824 incident cases. We think the result was credible since sufficient statistical power was achieved. Regarding to the inverse association of long sleep duration with prostate cancer and ovarian cancer, we believe the result might be due to chance since only one study with small cases was included for each cancer. Thus, further cohort studies with sufficient statistical power are required to confirm or refute the findings.
In this meta-analysis, about 8,392 incident cases and 555,678 participants were included, thus, we have sufficient statistical power to draw the conclusion. In addition, all included studies were prospective cohort based, thus, the conclusion is more convincing. Also, covariates’ estimates from individual study were used to pool the results. Thus, the estimate is more exact and the conclusion is more credible. However, our study is subject to four limitations. First, all included studies measured the sleep duration using the subjective questionnaire rather than the objective actigraphy. However, self-reported sleep duration assessment is well correlated with values obtained by actigraphic monitoring . Second, the confounding variables controlled for were different between studies. Further well-designed studies with consideration of more covariates are required to examine the association between sleep duration and cancer risk. Third, we had no data on sleep quality, the presence of sleeping disorders or rotating shift work, which may influence sleep duration and the association with cancer risk. Fourth, there was significant heterogeneity between studies. Thus, meta-regression meta-analysis was performed to examine source of heterogeneity, with introduction of variables including type of cancers, number of cases, mean age of subjects and duration of follow-up. The results suggested that type of cancers was the main source of heterogeneity (p<0.05). In the subgroup analysis by type of cancers, the heterogeneity disappeared in each subgroup with the exception for the subgroup of the association between breast cancer risk and short sleep duration.
In summary, the present meta-analysis suggested that neither short nor long sleep duration was significantly associated with risk of cancer, although long sleep duration increased risk of with colorectal cancer. Large-scale well-design prospective studies are necessary to be conducted to further confirm or refute the observed association.
Conceived and designed the experiments: ZH. Performed the experiments: JY YS. Analyzed the data: NT JY. Contributed reagents/materials/analysis tools: JY YS. Wrote the manuscript: YL.
- 1. Brzezinski A (1997) Melatonin in humans. N Engl J Med 336: 186–195. doi:10.1056/NEJM199701163360306. PubMed: 8988899.
- 2. Aeschbach D, Sher L, Postolache TT, Matthews JR, Jackson MA et al. (2003) A longer biological night in long sleepers than in short sleepers. J Clin Endocrinol Metab 88: 26–30. doi:10.1210/jc.2002-020827. PubMed: 12519823.
- 3. Chen X, Beydoun MA, Wang Y (2008) Is sleep duration associated with childhood obesity? A systematic review and meta-analysis. Obesity (Silver Spring) 16: 265-274. doi:10.1038/oby.2007.63.
- 4. Cappuccio FP, Taggart FM, Kandala NB, Currie A, Peile E et al. (2008) Meta-analysis of short sleep duration and obesity in children and adults. Sleep 31: 619-626. PubMed: 18517032.
- 5. Wang Q, Xi B, Liu M, Zhang Y, Fu M (2012) Short sleep duration is associated with hypertension risk among adults: a systematic review and meta-analysis. Hypertens Res 35: 1012-1018. doi:10.1038/hr.2012.91. PubMed: 22763475.
- 6. Guo X, Zheng L, Wang J, Zhang X, Zhang X et al. (2013) Epidemiological evidence for the link between sleep duration and high blood pressure: a systematic review and meta-analysis. Sleep Med 14: 324-332. doi:10.1016/j.sleep.2012.12.001. PubMed: 23394772.
- 7. Cappuccio FP, D’Elia L, Strazzullo P, Miller MA (2010) Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 33: 414-420. doi:10.2337/dc09-1124. PubMed: 19910503.
- 8. Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA (2011) Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J 32: 1484-1492. doi:10.1093/eurheartj/ehr007. PubMed: 21300732.
- 9. Cappuccio FP, D’Elia L, Strazzullo P, Miller MA (2010) Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 33: 585-592. PubMed: 20469800.
- 10. Gallicchio L, Kalesan B (2009) Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res 18: 148-158. doi:10.1111/j.1365-2869.2008.00732.x. PubMed: 19645960.
- 11. Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M et al. (2005) Sleep duration and breast cancer: a prospective cohort study. Cancer Res 65: 9595-9600. doi:10.1158/0008-5472.CAN-05-2138. PubMed: 16230426.
- 12. Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB (2006) A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 66: 5521-5525. doi:10.1158/0008-5472.CAN-05-4652. PubMed: 16707482.
- 13. Kakizaki M, Kuriyama S, Sone T, Ohmori-Matsuda K, Hozawa A et al. (2008) Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br J Cancer 99: 1502-1505. doi:10.1038/sj.bjc.6604684. PubMed: 18813313.
- 14. Kakizaki M, Inoue K, Kuriyama S, Sone T, Matsuda-Ohmori K et al. (2008) Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study. Br J Cancer 99: 176-178. doi:10.1038/sj.bjc.6604425. PubMed: 18542076.
- 15. Sturgeon SR, Luisi N, Balasubramanian R, Reeves KW (2012) Sleep duration and endometrial cancer risk. Cancer Causes Control 23: 547-553. doi:10.1007/s10552-012-9912-2. PubMed: 22362059.
- 16. Luo J, Sands M, Wactawski-Wende J, Song Y, Margolis KL (2013) Sleep disturbance and incidence of thyroid cancer in postmenopausal women the Women’s Health Initiative. Am J Epidemiol 177: 42-49. doi:10.1093/aje/kws193. PubMed: 23221728.
- 17. Weiderpass E, Sandin S, Inoue M, Shimazu T, Iwasaki M et al. (2012) Risk factors for epithelial ovarian cancer in Japan - results from the Japan Public Health Center-based Prospective Study cohort. Int J Oncol 40: 21-30. PubMed: 21904774.
- 18. Jiao L, Duan Z, Sangi-Haghpeykar H, Hale L, White DL et al. (2013) Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer 108: 213-221. doi:10.1038/bjc.2012.561. PubMed: 23287986.
- 19. Zhang X, Giovannucci EL, Wu K, Gao X, Hu F et al. (2013) Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep 36: 681-688. PubMed: 23633750.
- 20. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. doi:10.1016/0197-2456(86)90046-2. PubMed: 3802833.
- 21. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719–748. PubMed: 13655060.
- 22. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088–1101. doi:10.2307/2533446. PubMed: 7786990.
- 23. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629–634. doi:10.1136/bmj.315.7109.629. PubMed: 9310563.
- 24. McElroy JA, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM et al. (2006) Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep Res 15: 241-249. doi:10.1111/j.1365-2869.2006.00523.x. PubMed: 16911025.
- 25. Girschik J, Heyworth J, Fritschi L (2013) Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case-control study. Am J Epidemiol 177: 316-327. doi:10.1093/aje/kws422. PubMed: 23324334.
- 26. Wu AH, Stanczyk FZ, Wang R, Koh WP, Yuan JM et al. (2013) Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore. Int J Cancer 132: 891-896. doi:10.1002/ijc.27653. PubMed: 22644618.
- 27. Wu AH, Wang R, Koh WP, Stanczyk FZ, Lee HP et al. (2008) Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis 29: 1244-1248. doi:10.1093/carcin/bgn100. PubMed: 18448486.
- 28. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E (2005) Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 99: 2008-2019. doi:10.1152/japplphysiol.00660.2005. PubMed: 16227462.